These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 17116005)
1. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005 [TBL] [Abstract][Full Text] [Related]
2. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours. Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E; Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060 [TBL] [Abstract][Full Text] [Related]
3. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung. Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515 [TBL] [Abstract][Full Text] [Related]
4. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids. Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276 [TBL] [Abstract][Full Text] [Related]
5. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related]
6. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT). Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499 [TBL] [Abstract][Full Text] [Related]
7. FDG-PET imaging in patients with pulmonary carcinoid tumor. Moore W; Freiberg E; Bishawi M; Halbreiner MS; Matthews R; Baram D; Bilfinger TV Clin Nucl Med; 2013 Jul; 38(7):501-5. PubMed ID: 23486331 [TBL] [Abstract][Full Text] [Related]
8. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773 [TBL] [Abstract][Full Text] [Related]
10. Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours? Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE Eur J Cardiothorac Surg; 2017 May; 51(5):874-879. PubMed ID: 28204100 [TBL] [Abstract][Full Text] [Related]
11. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027 [TBL] [Abstract][Full Text] [Related]
13. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected? Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310 [TBL] [Abstract][Full Text] [Related]
14. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256 [TBL] [Abstract][Full Text] [Related]
15. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT. Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694 [TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. Pastorino U; Landoni C; Marchianò A; Calabrò E; Sozzi G; Miceli R; Picchio M; Mariani L; Messa C; Fazio F J Thorac Oncol; 2009 Nov; 4(11):1352-6. PubMed ID: 19861905 [TBL] [Abstract][Full Text] [Related]
18. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399 [TBL] [Abstract][Full Text] [Related]
20. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]